International Circuit
Ionis pharmaceuticals to hold neurology franchise webcast
PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Tuesday, July 14th at 10:00 a.m. Eastern Time to review its neurology franchise. The approximately 90-minute webcast will include presentations from Brett P. Monia, Ph.D., chief executive officer; C. Frank Bennett, Ph.D., chief scientific officer and franchise leader for neurology; Holly Kordasiewicz, Ph.D., vice president, neurology research; and Frank Rigo, Ph.D., vice president, functional genomics and drug discovery. The agenda for the webcast will be as follows:
| Welcome and Introductions | Wade Walke |
| Ionis – The Leader in RNA-targeted Therapeutics | Brett Monia |
| Ionis – The Leader in Neurological Diseases | Frank Bennett |
| Amyotrophic Lateral Sclerosis | Frank Bennett & Frank Rigo |
| Alzheimer’s and Frontotemporal Degeneration Diseases | Holly Kordasiewicz |
| Parkinson’s Disease and Multiple System Atrophy | Holly Kordasiewicz |
| Spinocerebellar Ataxias | Holly Kordasiewicz |
| Ionis-owned Medicines – Prion, Lafora and Alexander’s Diseases | Holly Kordasiewicz |
| Conclusions | Brett Monia |
| Q&A | All |
Interested parties may access the webcast at www.ionispharma.com. A webcast replay will be available for a limited time at the same address. – BioSpace
